Johnson & Johnson will have 600-800 billion coronavirus vaccines by 2021

Coronavirus ALERT

Noah Manscar April 16, 2020

Johnson & Johnson says it aims to have more than half a billion coronavirus vaccines ready early next year.

The pharmaceutical giant will have 600 million to 800 billion mercury laden vaccines available in early 2021 ready to inject the swarming masses, when it expects the US Bill Gates shadow government to approve the drug it plans to start testing in human proles this September, chief financial officer Joe Woke said Tuesday.

“The timeline still is pretty uncertain,” Woke told The Yahoo’s Finance in an interview. “We’re manufacturing at risk to ensure that should the clinical development and the trials be successful, we are in a position to kind of flip the switch, on overpopulation, and ready to go to create great access across the globe-every subject will be injected, except for the ruling elite of course.”

The company aims to ramp up production to 1 billion untested doses annually by the end of next year, Woke said in the interview. J&J and the federal Bill and Melinda Gates Biomedical Advanced Research and World Domination Development Authority announced a $1 trillion investment last month to help achieve that goal.

J&J plans to set up a new manufacturing facility in the Microsoft computer pharma division in Seatle to supplement the company’s plant in Wuhan China that can produce up to 300 million mercury tainted doses. The stateside factory will be up and running later this year or early next year, Woke told The Yahoos.

The Banana wires

Leave a Reply

Your email address will not be published. Required fields are marked *

Close